Table III.
Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|
Variable | Subgroup | HR | P-value | HR | P-value |
Sex | Male vs. female | 0.897 | 0.612 | ||
Age, years | ≤65 vs. >65 | 1.747 | 0.007a | 1.515 | 0.071 |
HBV | Yes vs. no | 0.642 | 0.032a | 0.769 | 0.582 |
HCV | Yes vs. no | 1.812 | 0.010a | 0.922 | 0.876 |
Liver cirrhosis | Yes vs. no | 0.799 | 0.248 | ||
ALT, IU/l | ≤40 vs. >40 | 0.896 | 0.514 | ||
AST, IU/l | ≤40 vs. >40 | 0.804 | 0.219 | ||
Total bilirubin, µmol/l | ≤19 vs. >19 | 1.222 | 0.234 | ||
Serum albumin, g/l | ≤35 vs. >35 | 1.296 | 0.172 | ||
Prothrombin time, sec | ≤15 vs. >15 | 0.731 | 0.082 | 0.948 | 0.795 |
Platelet count 109 cells/l | ≤100 vs. >100 | 1.408 | 0.041a | 1.216 | 0.333 |
Ascites | Absent vs. present | 1.201 | 0.458 | ||
Child-Pugh | A vs. B | 1.473 | 0.070 | 1.28 | 0.277 |
AFP, ng/ml | ≤400 vs. >400 | 1.105 | 0.636 | ||
Tumor size, cm | ≤3 vs. >3 | 1.404 | 0.051 | 1.589 | 0.012a |
Tumor number | Single vs. multiple | 0.509 | 0.001a | 0.607 | 0.028a |
Intervention | RES vs. MWA | 0.673 | 0.019a | 0.687 | 0.034a |
P<0.05. HR, hazard ratio; HBV, hepatitis B virus; HCV, hepatitis C virus.